Sheldon Sloan

SYRE

Sheldon Sloan serves as officer: Chief Medical Officer at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$7.35M

Net Position

Net Seller

$7.35M

Companies Traded

SYRE

Active Period

Apr 2026 – Jul 2026

4 total trades

Most Recent

Sell SYRE

Jul 2, 2026 · $730.9K

Sheldon Sloan's Insider Trading at Spyre Therapeutics, Inc. (SYRE)

Buys

0 · $0.00

Sells

4 · $7.35M

Total Shares Bought

Total Shares Sold

102,958

SYRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 2, 2026	Sell	8,334	$87.70	$730.9K	1,834
Jun 3, 2026	Sell	8,333	$75.00	$625.0K	0
May 1, 2026	Sell	78,333	$71.50	$5.60M	57,027
Apr 3, 2026	Sell	7,958	$50.00	$397.9K	0

Related Insiders

Scott L Burrows

officer: Chief Financial Officer

SYRESell · Sep 3, 2026

Heidy King-Jones

officer: See Remarks

SYRESell · Sep 3, 2026

Cameron Turtle

director, officer: Chief Executive Officer

SYRESell · Sep 3, 2026

Jeffrey W. Albers

director

SYRESell · Aug 10, 2026

Fairmount Funds Management LLC

director

SYRESell · Jun 23, 2026

HENDERSON MICHAEL THOMAS

director

SYRESell · Jun 23, 2026

Explore More Insider Trading Data

SYRE Insider Trading Activity

View all insider trades at Spyre Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity